Methamphetamine influences on recognition memory: comparison of escalating and single-day dosing regimens.

Neuropsychopharmacology 2008 May 18;33(6):1453-63. Epub 2007 Jul 18.

Department of Neurobiology and Behavior, University of California, Irvine, CA 92697-4550, USA.

Methamphetamine (mAMPH) is an addictive drug that produces memory and recall impairments in humans. Animals subjected to a binge mAMPH dosing regimen that damages brain dopamine and serotonin terminals show impairments in an object recognition (OR) task. Earlier research demonstrated that preceding a single-day mAMPH binge regimen with several days of increasing mAMPH doses greatly attenuates its neurotoxicity in rats. The escalating dose (ED) paradigm appears to mimic the human pattern of escalating drug intake. The current aim was to test whether an ED plus binge mAMPH regimen produces OR impairments. In addition to its translational value, this experiment helps address whether monoaminergic neurotoxicity accounts for OR impairments seen after mAMPH administration. To further address this issue, a separate experiment investigated both OR impairments and monoamine transporter integrity in groups of rats treated with a range of mAMPH doses during a single day. An ED mAMPH regimen attenuated the acute hyperthermic response to the subsequent mAMPH binge and prevented the OR impairments and reductions in [125 I]RTI-55 binding to monoamine transporters in striatum, hippocampus (HC), and perirhinal cortex (pRh) that otherwise occur 1 week after the mAMPH binge. Single-day mAMPH regimens (4 x 1mg/kg to 4 x 4 mg/kg, s.c.) dose-dependently produced acute hyperthermia and, 1 week post-mAMPH, produced dose-dependent impairments in OR and reductions in monoamine transporter binding. The OR impairments of single-day mAMPH-treated rats correlated with monoaminergic transporter loss in ventral caudate-putamen, HC, and pRh. In aggregate, these findings suggest a correspondence between mAMPH-induced monoaminergic injury and the resulting OR deficits.

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.npp.1301510DOI Listing
May 2008
4 Reads

Publication Analysis

Top Keywords

mamph binge
12
mamph
11
single-day mamph
8
binge mamph
8
mamph doses
8
impairments
8
monoamine transporter
8
impairments reductions
8
mamph regimen
8
binge
5
helps address
4
translational experiment
4
produced dose-dependent
4
experiment helps
4
address monoaminergic
4
accounts impairments
4
address issue
4
week post-mamph
4
issue separate
4
separate experiment
4

References

(Supplied by CrossRef)

KJ Axt et al.
Synapse 1991

A Badiani et al.
Behav Pharmacol 2004

AM Belcher et al.
Neuropsychopharmacology 2005

AM Belcher et al.
Behav Brain Res 2006

V Bisagno et al.
Brain Res 2002

V Bisagno et al.
Pharmacol Biochem Behav 2003

JW Boja et al.
Synapse 1992

JF Bowyer et al.
J Pharmacol Exp Ther 1994

JF Bowyer et al.
J Pharmacol Exp Ther 1992

LA Briand et al.
Learn Mem 2005

NJ Broadbent et al.
Proc Natl Acad Sci USA 2004

Similar Publications